S2MS2Medical AB (publ)
0.0044SEK-31.25%Mkt Cap: 4.90M SEKP/E: Last update: 2026-05-13

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)
P/E (Forward)
PEG
P/B0.49
P/S0.30
EV/EBITDA-2.88
EV/Revenue0.25
EPS (TTM)-0.02
EPS (Forward)
Cash Flow & Leverage
FCF Yield-6.15%
FCF Margin-1.87%
Operating CF5.03M SEK
CapEx (TTM)634.00K SEK
Net Debt/EBITDA0.65
Net Debt-907.00K SEK
Technical
SMA 500.0084 (-47.3%)
SMA 2000.0106 (-58.4%)
Beta2.29
S&P 52W Chg24.23%
Avg Vol (30d)4.90M
Avg Vol (10d)6.69M
Technical Indicators
RSI (14)24.3
MACD-0.0008
MACD Signal-0.0007
MACD Hist.-0.0002
BB Upper0.0095 SEK
BB Middle0.0073 SEK
BB Lower0.0051 SEK
BB Width59.38%
ATR (14)0.0013 SEK
Vol Ratio (20d)2.74x
52W Range
0.00421% of range0.0300
52W High0.0300 SEK
52W Low0.0042 SEK
Profitability
Gross Margin94.79%
EBITDA Margin-8.59%
Profit Margin32.78%
Oper. Margin-25.47%
ROE25.71%
ROA18.97%
Revenue Growth8.50%
Earnings Growth
Balance Sheet
Debt/Equity0.00
Current Ratio0.56
Quick Ratio0.25
Book Value/Sh0.0110 SEK
Cash/Share0.0010 SEK
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 SEK
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Ownership
Shares Out.898.66M
Float
Insiders46.43%
Institutions7.43%
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Company
Market Cap4.90M SEK
Enterprise Value3.99M SEK
Revenue (TTM)16.13M SEK
Gross Profit13.91M SEK
Net Income (TTM)4.81M SEK
Revenue/Share0.0190 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees
Last Price0.0044 SEK
CountrySE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN